2,127 results match your criteria: "'Metropolitan Hospital'[Affiliation]"
Neurology
November 2024
From the Department of Medical and Surgical Sciences (A.P., S.G., U.A., E.F.), Magna Graecia University of Catanzaro; Regional Epilepsy Centre (A.P., S.G., U.A., E.F.), Unit of Pediatrics (D.S., D.M.), Unit of Medical Genetics (C.M.), and Unit of Neurology (V.C., C.P.), "Bianchi-Melacrino-Morelli" Great Metropolitan Hospital, Reggio Calabria, Italy.
Pediatr Pulmonol
January 2025
Salesi Children Hospital Foundation, Ancona, Italy.
Clin Nutr
December 2024
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Department of Medicine, Boston VA Healthcare System, Boston, MA, USA. Electronic address:
Background & Aims: The effect of lipid-lowering treatment (LLT) on metabolic dysfunction associated steatotic liver disease (MASLD) is unclear. This is relevant for patients with familial hypercholesterolemia (FH) who are on lifelong LLT. We aimed to evaluate the effect of LLT on MASLD indices in this population.
View Article and Find Full Text PDFAnn Surg
October 2024
Hepatopancreatobiliary and Liver Transplant Surgery, Department of Surgery, Oncology and Gastroenterology (DiSCOG), University of Padua, Padua, Italy.
Objective: To validate the ISGPS definition and grading system of PPAP after pancreatoduodenectomy (PD).
Summary Background Data: In 2022, the International Study Group for Pancreatic Surgery (ISGPS) defined post-pancreatectomy acute pancreatitis (PPAP) and recommended a prospective validation of its diagnostic criteria and grading system.
Methods: This was a prospective, international, multicenter study including patients undergoing PD at 17 referral pancreatic centers across Europe, Asia, Oceania, and the United States.
Future Oncol
November 2024
CareAcross Ltd, London, UK.
Arch Cardiol Mex
October 2024
Emergency Department, Metropolitan Hospital Center, New York Medical College, New York City, EE.UU.
Obesity is a significant risk factor for the development of cardiovascular diseases. This review addresses the complex interaction between obesity and cardiovascular risk, highlighting dysfunctional adiposity as a crucial precursor in the metabolic renal cardiovascular continuum. The underlying pathophysiological mechanisms are reviewed, emphasizing the importance of risk identification and proper stratification, as well as the various available treatment strategies, including pharmacological and non-pharmacological interventions that have proven to reduce cardiovascular risk.
View Article and Find Full Text PDFNeurology
November 2024
From the Second Department of Neurology (L.P., A.T., A. Safouris, G. Tsivgoulis), "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece; Department of Medicine (Neurology) (A.H.K.), McMaster University/Population Health Research Institute, Hamilton, Ontario, Canada; Department of Neurology (Guillaume Turc), GHU Paris Psychiatrie et Neurosciences; Université Paris Cité (G. Turc); INSERM U1266 (G. Turc); FHU NeuroVasc (G. Turc), Paris, France; Department of Primary Education (A.-G.A., D.M.), University of Ioannina, Greece; Department of Neurology and Neurogeriatrics (P.D.S.), Johannes Wesling Klinikum Minden, Ruhr-University Bochum, Germany; Department of Neurology (R.L.), University Hospitals Leuven; Division of Experimental Neurology (R.L.), Department of Neurosciences, KU Leuven-University of Leuven, Belgium; Department of Biotechnological and Applied Clinical Sciences (S.S.), University of L'Aquila, Italy; Stroke Unit (A. Safouris), Metropolitan Hospital, Piraeus, Greece; Department of Neurology (M.K., U.F.), University Hospital Basel, University of Basel, Switzerland; Department of Neurology (A. Sarraj), Case Western Reserve University, University Hospitals Cleveland Medical Center, OH; and Department of Neurology (U.F.), University Hospital Bern, University of Bern, Switzerland.
Cureus
September 2024
Anesthesiology, New York Medical College, Metropolitan Hospital Center, New York, USA.
Cardiovasc Revasc Med
September 2024
Brookdale Hospital Center, Department: Cardiology, United States of America.
Cureus
September 2024
Neuroradiology, University College London, London, GBR.
[This corrects the article DOI: 10.7759/cureus.59915.
View Article and Find Full Text PDFAm J Clin Dermatol
November 2024
School of Medicine, New York Medical College, 40 Sunshine Road, Valhalla, NY, 10595, USA.
Ther Adv Neurol Disord
September 2024
Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Rimini 1, Chaidari, Athens 12462, Greece.
Obes Surg
November 2024
Department of Minimally Invasive Digestive & Bariatric Surgery, Metropolitan Hospital, Athens, Greece.
Lancet Neurol
October 2024
Department of Neurosurgery, Barrow Neurological Institute, St Joseph's Hospital and Medical Center, Phoenix, Arizona, USA.
Lung Cancer
October 2024
Department of Oncology, Università degli Studi Di Torino - San Luigi Hospital Orbassano, Italy.
Cutis
August 2024
Danielle Garcia and Dr. Farr are from Baylor College of Medicine, Houston, Texas. Dr. Ross is from Methodist Metropolitan Hospital, San Antonio, Texas.
Int J Health Sci (Qassim)
January 2024
Department of Pathology, College of Medicine, Qassim University, Buraydah, Saudi Arabia.
Objective: The objective of this systematic review was to describe novel regimens and treatment strategies in neoadjuvant therapy for colorectal cancer (CRC). The aim was to summarize the current advancements in neoadjuvant chemotherapy (NACT) for CRC, including the use of cytotoxic drugs, targeted treatments, and immunotherapy. The analysis aimed to provide insights into the potential benefits and drawbacks of these novel approaches and highlight the need for further research to optimize NACT use in CRC and improve patient outcomes.
View Article and Find Full Text PDFHeart Rhythm
September 2024
Cardiac Arrhythmia Department, Great Metropolitan Hospital Niguarda, Milan, Italy.
Background: Enhanced characterization of the atrial electrical substrate may lead to better comprehension of atrial fibrillation (AF) pathophysiology.
Objective: With the use of high-density substrate mapping, we sought to investigate the occurrence of functional electrophysiological phenomena in the left atrium and to assess potential association with arrhythmia recurrences after catheter ablation.
Methods: Sixty-three consecutive patients with AF referred for ablation were enrolled.
Cancer Treat Rev
November 2024
Oncology Institute of Southern Switzerland, EOC-IOSI, Via A. Gallino 12, CH - 6500 Bellinzona, Switzerland. Electronic address:
The aim of this review is to provide an overview of the status of patient/public involvement (PPI) in oncology research, including definitions, regulatory aspects, ongoing clinical activities in different countries, achievements and difficulties. The 10-year activities of the Swiss Group for Clinical Cancer Research (SAKK) Patient Advisory Board are described, illustrating challenges faced and solutions in daily practice. Even though clinical data are still limited, it appears PPI has great potential for development in oncology.
View Article and Find Full Text PDFJ Neurol Sci
November 2024
Second Department of Neurology, "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens, Greece.
Heart failure (HF) is an important comorbidity for patients with ischemic stroke, present in 11 %-18 % of patients, and may also independently increase the risk of first-ever and recurrent ischemic stroke. HF is categorized based on ejection fraction (EF) into HF with reduced (HFrEF), mildly-reduced (HFmrEG) and preserved ejection fraction (HFpEF), with the efficacy of HF therapies differing between the three subcategories. Despite this classification, the incidence, recurrence rates and outcomes of ischemic stroke do not appear to differ significantly between the three subtypes, even when considering the concurrent presence of atrial fibrillation.
View Article and Find Full Text PDFNeurology
October 2024
From the Second Department of Neurology (A.T., K.M., E.B., M.C., M.I.S., L.P., S.G., G.T.), "Attikon" University Hospital, School of Medicine, National and Kapodistrian University of Athens; Department of Neurology (A.K., P.P.), Korgialenio-Benakio Greek Red Cross General Hospital of Athens; Stroke Unit (K.P., A. Safouris, O.K.), Metropolitan Hospital, Piraeus; Department of Neurology (E.N.), School of Medicine, University of Ioannina, Greece; Department of Neurology (A. Sarraj), University Hospital Cleveland Medical Center, Case Western Reserve University, OH; Department of Neurology (D.J.S.), Inselspital, Bern University Hospital, University of Bern, Switzerland; and Department of Neurology (G.T.), University of Tennessee Health Science Center, Memphis.
Disaster Med Public Health Prep
September 2024
Department of Emergency Medicine, New York City Health + Hospitals/Metropolitan Hospital, New York, New York, USA.
The recent rise of active shootings calls for adequate preparation. Currently, the "Run, Hide, Fight" concept is widely accepted and adopted by many hospitals nationwide. Unfortunately, the appropriateness of this concept in hospitals is uncertain due to lack of data.
View Article and Find Full Text PDF